Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease (Stroke. — 2003. —Mar. — 34(3). — P. 632—636: англ.)

D. Tanne; Tanne D.; M. Haim; Haim M.; U. Goldbourt; Goldbourt U.; V. Boyko; Boyko V.; R. Doolman; Doolman R.; Y. Adler; Adler Y.; D. Brunner; Brunner D.; S. Behar; Behar S.; B. Sela; Sela B.

doi:10.17816/nb89680

Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease (Stroke. — 2003. —Mar. — 34(3). — P. 632—636: англ.)

Authors: Tanne D.¹, Haim M.¹, Goldbourt U.¹, Boyko V.¹, Doolman R.¹, Adler Y.¹, Brunner D.¹, Behar S.¹, Sela B.¹
Affiliations:
1. Chaim Sheba Medical Center
Issue: Vol XXXV, No 1-2 (2003)
Pages: 78-79
Section: Abstracts
URL: https://journals.rcsi.science/1027-4898/article/view/89680
DOI: https://doi.org/10.17816/nb89680
ID: 89680

Cite item

Full Text

Abstract
Full Text
About the authors
References
Statistics

Abstract

According to modern data, homocysteine damages the vascular endothelium, contributing to the formation of lipid plaques and blood clots. The aim of the study was to determine the risk of ischemic stroke in persons with coronary heart disease, depending on the level of homocysteine in the blood serum.